Pet Drug Development Evaluation (24 results)
Language: English
Published by Kluwer Academic Publishers, Dordrecht, The Netherlands 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
Seller: PsychoBabel & Skoob Books, Didcot, United KingdomPsychoBabel & Skoob Books
Contact seller5-star sellerCondition: Used - Very good
£ 97.00
£ 12.50 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Hardcover. Condition: Very Good. Hardcover in very good condition. No jacket. Previous owner's name penned on FEP. Pages are clean and text is clear throughout. HCW. Used.
Language: English
Published by Springer 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
£ 137.84
£ 11.98 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Language: English
Published by Springer 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
£ 137.84
£ 11.98 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Language: English
Published by Springer 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: New
£ 156.52
£ 1.98 shippingShips within U.S.A.Quantity: 15 available
Condition: New.
Language: English
Published by Springer 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: New
£ 157.91
£ 1.98 shippingShips within U.S.A.Quantity: 15 available
Condition: New.
Language: English
Published by Springer 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: Used - As new
£ 174.38
£ 1.98 shippingShips within U.S.A.Quantity: 15 available
Condition: As New. Unread book in perfect condition.
More imagesLanguage: English
Published by Springer Netherland 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 125.83
£ 60.56 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. PET for Drug Development and Evaluation | D. Comar | Taschenbuch | viii | Englisch | 2012 | Springer Netherland | EAN 9789401041911 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Language: English
Published by Springer Netherlands 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 150.36
£ 54.48 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Can drug development and evaluation be improved by the use of positron emission tomography (PET) PET is now well established and many PET centres participate in networks that warrant the quality of their research. PET allows one to follow the effec…t of a drug on a variety of patients' metabolic parameters. In addition, PET may be used to follow the fate in vivo of a compound, allowing visualisation of its binding to specific receptors and a direct study of the mechanism of drug action in normal and pathological situations. The book shows the fields in which PET offers new and unique information for the development of drugs (conception, toxicity, pharmacokinetics and metabolism, clinical research, and relations between clinical and biological effects) and evaluates fields in which PET may shorten the development time of drugs. Audience: Professionals in the pharmaceutical industry in all areas of drug discovery and pharmacology, pre-clinical testing, pharmacokinetics and metabolism, clinical evaluation, registration and regulatory affairs. Government health authority representatives who assess data and documentation on new drug development and radiopharmaceuticals. Academic experts concerned with any of these areas.
Language: English
Published by Springer 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: New
£ 208.74
£ 3.00 shippingShips within U.S.A.Quantity: 4 available
Condition: New. pp. 372.
Language: English
Published by Springer Netherlands, Springer Netherlands 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 152.06
£ 56.15 shippingShips from Germany to U.S.A.Quantity: 1 available
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Can drug development and evaluation be improved by the use of positron emission tomography (PET) PET is now well established and many PET centres participate in networks that warrant the quality of their research. PET allows one to follow the effect of a…drug on a variety of patients' metabolic parameters. In addition, PET may be used to follow the fate in vivo of a compound, allowing visualisation of its binding to specific receptors and a direct study of the mechanism of drug action in normal and pathological situations. The book shows the fields in which PET offers new and unique information for the development of drugs (conception, toxicity, pharmacokinetics and metabolism, clinical research, and relations between clinical and biological effects) and evaluates fields in which PET may shorten the development time of drugs. Audience: Professionals in the pharmaceutical industry in all areas of drug discovery and pharmacology, pre-clinical testing, pharmacokinetics and metabolism, clinical evaluation, registration and regulatory affairs. Government health authority representatives who assess data and documentation on new drug development and radiopharmaceuticals. Academic experts concerned with any of these areas.
Language: English
Published by Springer Verlag 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
Seller: Revaluation Books, Exeter, , United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
£ 197.03
£ 12.50 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Paperback. Condition: Brand New. reprint edition. 372 pages. 9.45x6.30x0.88 inches. In Stock.
Language: English
Published by Springer 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
Seller: Revaluation Books, Exeter, , United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
£ 198.69
£ 15.00 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Hardcover. Condition: Brand New. 1st edition. 360 pages. 10.00x7.00x1.00 inches. In Stock.
Language: English
Published by Springer 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
Seller: Mispah books, Redhill, SURRE, United KingdomMispah books
Contact seller4-star sellerCondition: Used - As new
£ 207.00
£ 25.00 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Hardcover. Condition: Like New. Like New. book.
Language: English
Published by Springer 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: Used - As new
£ 245.61
£ 1.98 shippingShips within U.S.A.Quantity: 15 available
Condition: As New. Unread book in perfect condition.
Language: English
Published by Springer 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
- Print on Demand
Seller: Brook Bookstore On Demand, Napoli, NA, ItalyBrook Bookstore On Demand
Contact seller3-star sellerCondition: New
£ 112.51
£ 5.88 shippingShips from Italy to U.S.A.Quantity: Over 20 available
Condition: new. Questo è un articolo print on demand.
Language: English
Published by Springer Netherlands 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
- Print on Demand
Seller: moluna, Greven, , Germanymoluna
Contact seller5-star sellerCondition: New
£ 121.33
£ 42.38 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Can drug development and evaluation be improved by the use of positron emission tomography (PET)? PET is now well established and many PET centres participate in networks that warrant the quality of their research. PE…T allows one to follow the effect of .
Language: English
Published by Springer Netherlands Nov 1995 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
£ 143.01
£ 19.90 shippingShips from Germany to U.S.A.Quantity: 2 available
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Can drug development and evaluation be improved by the use of positron emission tomography (PET) PET is now well established and many PET centres participate in networks that warrant the quality of their research. PET allows one to follow…the effect of a drug on a variety of patients' metabolic parameters. In addition, PET may be used to follow the fate in vivo of a compound, allowing visualisation of its binding to specific receptors and a direct study of the mechanism of drug action in normal and pathological situations. The book shows the fields in which PET offers new and unique information for the development of drugs (conception, toxicity, pharmacokinetics and metabolism, clinical research, and relations between clinical and biological effects) and evaluates fields in which PET may shorten the development time of drugs. Audience: Professionals in the pharmaceutical industry in all areas of drug discovery and pharmacology, pre-clinical testing, pharmacokinetics and metabolism, clinical evaluation, registration and regulatory affairs. Government health authority representatives who assess data and documentation on new drug development and radiopharmaceuticals. Academic experts concerned with any of these areas. 372 pp. Englisch.
Language: English
Published by Springer Netherlands 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
- Print on Demand
Seller: moluna, Greven, , Germanymoluna
Contact seller5-star sellerCondition: New
£ 121.33
£ 42.38 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Can drug development and evaluation be improved by the use of positron emission tomography (PET)? PET is now well established and many PET centres participate in networks that warrant the quality of their re…search. PET allows one to follow the effect of .
More imagesLanguage: English
Published by Springer Netherland 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
- Print on Demand
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 125.83
£ 60.56 shippingShips from Germany to U.S.A.Quantity: 5 available
Buch. Condition: Neu. PET for Drug Development and Evaluation | D. Comar | Buch | viii | Englisch | 1995 | Springer Netherland | EAN 9780792337164 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Language: English
Published by Springer Netherlands, Springer Netherlands Nov 1995 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
£ 143.01
£ 51.91 shippingShips from Germany to U.S.A.Quantity: 1 available
Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Can drug development and evaluation be improved by the use of positron emission tomography (PET) PET is now well established and many PET centres participate in networks that warrant the quality of their research. PET allows one to follow the…effect of a drug on a variety of patients' metabolic parameters. In addition, PET may be used to follow the fate in vivo of a compound, allowing visualisation of its binding to specific receptors and a direct study of the mechanism of drug action in normal and pathological situations.The book shows the fields in which PET offers new and unique information for the development of drugs (conception, toxicity, pharmacokinetics and metabolism, clinical research, and relations between clinical and biological effects) and evaluates fields in which PET may shorten the development time of drugs.Audience: Professionals in the pharmaceutical industry in all areas of drug discovery and pharmacology, pre-clinical testing, pharmacokinetics and metabolism, clinical evaluation, registration and regulatory affairs. Government health authority representatives who assess data and documentation on new drug development and radiopharmaceuticals. Academic experts concerned with any of these areas.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 372 pp. Englisch.
Language: English
Published by Springer Netherlands, Springer Netherlands Okt 2012 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
£ 143.01
£ 51.91 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Can drug development and evaluation be improved by the use of positron emission tomography (PET) PET is now well established and many PET centres participate in networks that warrant the quality of their research. PET allows one to foll…ow the effect of a drug on a variety of patients' metabolic parameters. In addition, PET may be used to follow the fate in vivo of a compound, allowing visualisation of its binding to specific receptors and a direct study of the mechanism of drug action in normal and pathological situations.The book shows the fields in which PET offers new and unique information for the development of drugs (conception, toxicity, pharmacokinetics and metabolism, clinical research, and relations between clinical and biological effects) and evaluates fields in which PET may shorten the development time of drugs.Audience: Professionals in the pharmaceutical industry in all areas of drug discovery and pharmacology, pre-clinical testing, pharmacokinetics and metabolism, clinical evaluation, registration and regulatory affairs. Government health authority representatives who assess data and documentation on new drug development and radiopharmaceuticals. Academic experts concerned with any of these areas.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 372 pp. Englisch.
Language: English
Published by Springer 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
- Print on Demand
Seller: Majestic Books, Hounslow, , United KingdomMajestic Books
Contact seller4-star sellerCondition: New
£ 216.87
£ 6.50 shippingShips from United Kingdom to U.S.A.Quantity: 4 available
Condition: New. Print on Demand pp. 372.
Language: English
Published by Springer 1995
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Hardcover
- Print on Demand
Seller: Biblios, frankfurt am main, HESSE, GermanyBiblios
Contact seller4-star sellerCondition: New
£ 222.98
£ 8.61 shippingShips from Germany to U.S.A.Quantity: 4 available
Condition: New. PRINT ON DEMAND pp. 372.
Language: English
Published by Springer Netherlands Okt 2012 2012
Series: Developments in Nuclear Medicine, Book 11 of 33. Book 11 of 33 - Developments in Nuclear Medicine
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
£ 213.58
£ 19.90 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Can drug development and evaluation be improved by the use of positron emission tomography (PET) PET is now well established and many PET centres participate in networks that warrant the quality of their research. PET allows one to…follow the effect of a drug on a variety of patients' metabolic parameters. In addition, PET may be used to follow the fate in vivo of a compound, allowing visualisation of its binding to specific receptors and a direct study of the mechanism of drug action in normal and pathological situations. The book shows the fields in which PET offers new and unique information for the development of drugs (conception, toxicity, pharmacokinetics and metabolism, clinical research, and relations between clinical and biological effects) and evaluates fields in which PET may shorten the development time of drugs. Audience: Professionals in the pharmaceutical industry in all areas of drug discovery and pharmacology, pre-clinical testing, pharmacokinetics and metabolism, clinical evaluation, registration and regulatory affairs. Government health authority representatives who assess data and documentation on new drug development and radiopharmaceuticals. Academic experts concerned with any of these areas. 372 pp. Englisch.
